MedPath
FDA Approval

SYMPROIC

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
December 23, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Naldemedine(0.2 mg in 1 1)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

SYMPROIC

Product Details

NDC Product Code
59385-041
Application Number
NDA208854
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
July 30, 2021
Code: V1N8F1RVVOClass: ACTIMQuantity: 0.2 mg in 1 1
Magnesium StearateInactive
Code: 70097M6I30Class: IACT
Ferric Oxide YellowInactive
Code: EX438O2MRTClass: IACT
MannitolInactive
Code: 3OWL53L36AClass: IACT
Croscarmellose SodiumInactive
Code: M28OL1HH48Class: IACT
Hypromellose, UnspecifiedInactive
Code: 3NXW29V3WOClass: IACT
TalcInactive
Code: 7SEV7J4R1UClass: IACT
© Copyright 2025. All Rights Reserved by MedPath